Cargando…

Progesterone inhibits contraction and increases TREK-1 potassium channel expression in late pregnant rat uterus

OBJECTIVE: The aim of this study was to investigate the effect and mechanism by which progesterone regulates uterine contraction in late pregnant rats RESULTS: Progesterone caused concentration-dependent relaxation of uterine strips that was enhanced compared with control nontreated uterine strips....

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Zongzhi, Li, Yun, He, Wenzhu, Li, Dan, Li, Hongyan, Yang, Yuanyuan, Shen, Bing, Wang, Xi, Cao, Yunxia, Khalil, Raouf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787496/
https://www.ncbi.nlm.nih.gov/pubmed/29416642
http://dx.doi.org/10.18632/oncotarget.23084
Descripción
Sumario:OBJECTIVE: The aim of this study was to investigate the effect and mechanism by which progesterone regulates uterine contraction in late pregnant rats RESULTS: Progesterone caused concentration-dependent relaxation of uterine strips that was enhanced compared with control nontreated uterine strips. Uterine strips incubated with progesterone showed a significant increase in TREK-1 mRNA expression and protein level. TREK-1 inhibitor L-methionine partly reversed uterine relaxation caused by the progesterone, while TREK-1 activator arachidonic acid did not cause significant change in progesterone-induced relaxation. CONCLUSIONS: Progesterone inhibits uterine contraction and induces uterine relaxation in late pregnancy. The progesterone-induced inhibition of uterine contraction appears to partly involve increased potassium channel TREK-1 expression/activity. MATERIALS AND METHODS: Uterus from late-pregnant rats (gestational day 19) was isolated, and uterine strips were prepared for isometric contraction measurement. Oxytocin-induced contraction was compared in uterine strips pretreated with different concentration of progesterone. TREK-1 potassium channel inhibitor L-methionine and TREK-1 agonist arachidonic acid were used to determine whether the changes caused by progesterone involve changes in TREK-1 activity. The mRNA and protein expression of TREK-1 in uterine tissues were measured using qPCR and Western blot.